323. Disorders of Coagulation, Bleeding, or Fibrinolysis, Excluding Congenital Hemophilias: Clinical and Epidemiological: Poster II

Acquired factor v inhibitor and granulomatosis with polyangiitis Diagnostic challenges and therapeutic implications

Acquired Hemophilia A AHA associated with monoclonal gammopathy A single institution case series

Trends in coagulation defects related mortality in adults in the United States a retrospective analysis from 1999 2023

A 10 year retrospective review of the effectiveness and safety of tranexamic acid in women with inherited bleeding disorders in the peripartum setting

Real world treatment characteristics and outcomes in patients with von Willebrand disease treated prophylactically with plasma derived or recombinant von Willebrand factor in europe A multi center retrospective study

Efficacy and safety of tranexamic acid in non haemophilia bleeding disorders A systematic review of randomized controlled trials

Pharmacokinetic pharmacodynamic modelling of von willebrand factor factor VIII prophylaxis in von willebrand disease

Unusual laboratory manifestations of fibrinogen γ chain p Ala108Gly genetic variant A case report

Peripartum FXI replacement supports safe neuraxial anesthesia in FXI deficient parturients

Acquired hemophilia a results from a provincial registry highlight the need for improvement of clinical outcomes and bypassing agent use

Implementation of 2020 international guidelines in acquired hemophilia Insights from a decade of national registry data in Spain